{"id":18965,"date":"2023-03-09T17:03:49","date_gmt":"2023-03-09T17:03:49","guid":{"rendered":"https:\/\/clinlabint.com\/?p=18965"},"modified":"2023-03-09T17:03:49","modified_gmt":"2023-03-09T17:03:49","slug":"siemens-healthineers-and-sysmex-establish-global-agreement-to-supply-hemostasis-instruments-reagents-as-oems","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/siemens-healthineers-and-sysmex-establish-global-agreement-to-supply-hemostasis-instruments-reagents-as-oems\/","title":{"rendered":"Siemens Healthineers and Sysmex establish global agreement to supply hemostasis instruments, reagents as OEMs"},"content":{"rendered":"<div id='av_section_1'  class='avia-section main_color avia-section-default avia-no-border-styling  avia-bg-style-scroll  avia-builder-el-0  avia-builder-el-no-sibling   container_wrap fullsize' style=' '  ><div class='container' ><main  role=\"main\" itemprop=\"mainContentOfPage\"  class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-18965'><div class='entry-content-wrapper clearfix'>\n<div class=\"flex_column av_one_fifth  av-hide-on-mobile  flex_column_div av-zero-column-padding first  avia-builder-el-1  el_before_av_three_fifth  avia-builder-el-first  \" style='border-radius:0px; '><section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p style=\"text-align: center\"><!--Begin ClixTrac.com Banner Code -->\r\n<a href=\"https:\/\/clixtrac.com\/goto\/?311442\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/clixtrac.com\/banner\/311442.jpg\" alt=\"Bio-Rad - Preparing for a Stress-free QC Audit\" title=\"Bio-Rad - Preparing for a Stress-free QC Audit\" border=\"0\" \/><\/a>\r\n<!--End ClixTrac.com Banner Code --><\/p>\n<\/div><\/section><\/div><div class=\"flex_column av_three_fifth  flex_column_div av-zero-column-padding   avia-builder-el-3  el_after_av_one_fifth  el_before_av_one_fifth  \" style='border-radius:0px; '><section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p style=\"text-align: center\"><\/p>\n<\/div><\/section><br \/>\n<section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><header class=\"entry-content-header\"><h1 class=\"post-title entry-title\" itemprop=\"headline\">Siemens Healthineers and Sysmex establish global agreement to supply hemostasis instruments, reagents as OEMs<\/h1><span class=\"post-meta-infos\">\/ <span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/clinlabint.com\/e-news\/\" rel=\"tag\">E-News<\/a>  <\/span><\/span><\/header>\n<\/div><\/section><br \/>\n<section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><ul type=\"disc\">\n<li class=\"bodytext\">\n<h3><strong><span lang=\"EN-US\">Building on a 25+ year partnership, the companies will each provide one of the largest hemostasis testing system and reagent portfolios to laboratories.<\/span><\/strong><\/h3>\n<\/li>\n<li class=\"bodytext\">\n<h3><strong><span lang=\"EN-US\">Under the multi-year agreement, both companies will individually distribute their combined portfolio of hemostasis instruments and reagents worldwide under their respective own brands.<\/span><\/strong><\/h3>\n<\/li>\n<\/ul>\n<p><!--more--><\/p>\n<p>On February 28, 2023, Siemens Healthineers signed a global OEM agreement on hemostasis products with Sysmex Corporation under which each company will supply the other with their products in the diagnostic field of hemostasis on an OEM basis. Siemens Healthineers and Sysmex provide, among other things, hemostasis products used in testing for blood clotting disorders, preoperative bleeding risk management, and the monitoring of patients receiving anticoagulant therapy medications. The OEM agreement positions each company to distribute\u2014globally and individually\u2014under their respective brands the companies&#8217; combined portfolio of hemostasis instruments and reagents, in combination with their own wider portfolios of products and services.<sup>1<\/sup> Going forward, the companies will each individually offer effective solutions to laboratories worldwide that build on their respective strengths based on one of the world\u2019s most extensive hemostasis product portfolios realized through the collaboration to meet diversifying customer needs.<\/p>\n<\/div><\/section><br \/>\n<div  class='avia-image-container  av-styling-    avia-builder-el-7  el_after_av_textblock  el_before_av_textblock  avia-align-center '  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\"  ><div class='avia-image-container-inner'><div class='avia-image-overlay-wrap'><img decoding=\"async\" class=\"avia_image\" src=\"https:\/\/clinlabint.com\/wp-content\/uploads\/sites\/2\/2023\/03\/Healthineers_Logo-1030x732.jpg\" alt=\"\" title=\"Healthineers_Logo\" height=\"732\" width=\"1030\" itemprop=\"thumbnailUrl\"><\/div><\/div><\/div><br \/>\n<section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p class=\"bodytext\"><span lang=\"EN-US\">&#8220;Siemens Healthineers and Sysmex have built a solid hemostasis partnership for more than 25 years,&#8221; said Sharon Bracken, Head of Diagnostics for Siemens Healthineers. &#8220;The time has come to offer one of the world\u2019s most extensive product portfolios achieved through mutual OEM supply to benefit customers and patients worldwide. With the OEM agreement, we will more effectively deliver quality and comprehensive hemostasis testing solutions to laboratories of all sizes across the world.&#8221;<\/span><\/p>\n<p class=\"bodytext\"><span lang=\"EN-US\">\u00a0<\/span><\/p>\n<p class=\"bodytext\"><span lang=\"EN-US\">\u201cMaking our long-standing partnership with Siemens Healthineers even more sustainable, we remain committed to further enhance the value of hemostasis testing as a global leader,\u201d states Kenji Tachibana, Member of the Managing Board and Senior Executive Officer, Senior Managing Director of Sysmex. \u201cWe will individually offer laboratories worldwide proprietary solutions with the benefit of our respective expertise and service portfolio, providing customers with access to the broadest set of solutions in the evolving market.\u201d<\/span><\/p>\n<p class=\"bodytext\"><span lang=\"EN-US\">\u00a0<\/span><\/p>\n<p class=\"bodytext\"><span lang=\"EN-US\">Since entering into a global agreement on distribution, sales, and services for hemostasis products in 1995, the two companies have built a solid partnership becoming one of the leading solution providers in the global hemostasis segment. During this period, the companies also have expanded their capabilities and enhanced their individual strengths through innovation in their respective portfolios.<\/span><\/p>\n<p class=\"bodytext\"><span lang=\"EN-US\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/p>\n<p class=\"bodytext\"><span lang=\"EN-US\">In recent years, demand for hemostasis testing has increased and grown more diverse because of a rise in thrombotic diseases stemming from lifestyle diseases, the development of new blood preparations, the use in testing to predict COVID-19 severity, as well as increased demands for standardization, IT connectivity, and quality improvement in testing.<\/span><\/p>\n<p class=\"bodytext\"><span lang=\"EN-US\">\u00a0<\/span><\/p>\n<p class=\"bodytext\"><span lang=\"EN-US\">Under the OEM agreement the companies expect to each individually offer laboratories even more compelling, effective hemostasis solutions on a global scale, to address customers\u2019 changing testing environments and to enable better access to care to improve patient outcomes for patients worldwide. Through this strengthened partnership, the companies further demonstrate their commitment to continually advance hemostasis testing.<\/span><\/p>\n<p class=\"bodytext\" align=\"center\"><span lang=\"EN-US\">\u00a0<\/span><\/p>\n<p class=\"bodytext\">Further information is available at<span class=\"apple-converted-space\">\u00a0<\/span><a title=\"https:\/\/eur04.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fu7061146.ct.sendgrid.net%2Fls%2Fclick%3Fupn%3DTeZUXWpUv-2B6TCY38pVLo9gj3VP4WVuLzrkQRHw8a-2FOuLgR5i1cX3lOnGsL4P-2BisnhX7s_0rFChhUgBDmdehLIVtwPfX7WkR-2FnG-2F2irh28XfMorbxmGF9UzrKpaZTsXlEibiGh\" href=\"https:\/\/eur04.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fu7061146.ct.sendgrid.net%2Fls%2Fclick%3Fupn%3DTeZUXWpUv-2B6TCY38pVLo9gj3VP4WVuLzrkQRHw8a-2FOuLgR5i1cX3lOnGsL4P-2BisnhX7s_0rFChhUgBDmdehLIVtwPfX7WkR-2FnG-2F2irh28XfMorbxmGF9UzrKpaZTsXlEibiGhB5twfONEJffQtu2F0MdWVQHrsINSdLbyCglmmaLC7fUoRO56FXOI6ITtS0WYMk-2FJ4mb1yajDTcWj4-2FIRku-2BOCnJhuV8yN0xazMYq4ojZo-2B-2FJZJdqQoJQMKNw4gLjek2KUJbjlc7zhrXvZUxZojiJLWXbZHNNYAb2tYuTVM75drLdYWuFcDaBg6AxTuxUzK7ojF-2FSW-2FUya6UABCUOb-2FbyUp2sfsrEzyq0m0MDKEc-2BfAvjF6OTdDdhWBJ7ksvxfHi2lOUSurGyz7hsNqI8yh-2FUpNCcvTZv1CEeD3IM5xuZzE8-3D&amp;data=05%7C01%7CKimberly.Nissen%40siemens-healthineers.com%7C730ab7833d2e49ca281108db20831af4%7C5dbf1add202a4b8d815bbf0fb024e033%7C0%7C0%7C638139520195937661%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C2000%7C%7C%7C&amp;sdata=ZFYgwUlZm86AGR0hH19eLzWyHYiVppxhqQ3Q3VbKTI4%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener noreferrer\">www.siemens-healthineers.com<\/a>.<\/p>\n<\/div><\/section><br \/>\n<div  class='av-social-sharing-box  avia-builder-el-9  el_after_av_textblock  avia-builder-el-last  av-social-sharing-box-minimal '><div class='av-share-box'><h5 class='av-share-link-description av-no-toc '>Share this<\/h5><ul class='av-share-box-list noLightbox'><li class='av-share-link av-social-link-facebook' ><a target=\"_blank\" aria-label=\"Share on Facebook\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https:\/\/clinlabint.com\/siemens-healthineers-and-sysmex-establish-global-agreement-to-supply-hemostasis-instruments-reagents-as-oems\/&#038;t=Siemens%20Healthineers%20and%20Sysmex%20establish%20global%20agreement%20to%20supply%20hemostasis%20instruments%2C%20reagents%20as%20OEMs\" aria-hidden=\"false\" data-av_icon=\"\ue8f3\" data-av_iconfont=\"entypo-fontello\" title=\"\" data-avia-related-tooltip=\"Share on Facebook\" rel=\"noopener\"><span class='avia_hidden_link_text'>Share on Facebook<\/span><\/a><\/li><li class='av-share-link av-social-link-twitter' ><a target=\"_blank\" aria-label=\"Share on Twitter\" href=\"https:\/\/twitter.com\/share?text=Siemens%20Healthineers%20and%20Sysmex%20establish%20global%20agreement%20to%20supply%20hemostasis%20instruments%2C%20reagents%20as%20OEMs&#038;url=https:\/\/clinlabint.com\/?p=18965\" aria-hidden=\"false\" data-av_icon=\"\ue8f1\" data-av_iconfont=\"entypo-fontello\" title=\"\" data-avia-related-tooltip=\"Share on Twitter\" rel=\"noopener\"><span class='avia_hidden_link_text'>Share on Twitter<\/span><\/a><\/li><li class='av-share-link av-social-link-whatsapp' ><a target=\"_blank\" aria-label=\"Share on WhatsApp\" href=\"https:\/\/api.whatsapp.com\/send?text=https:\/\/clinlabint.com\/siemens-healthineers-and-sysmex-establish-global-agreement-to-supply-hemostasis-instruments-reagents-as-oems\/\" aria-hidden=\"false\" data-av_icon=\"\uf232\" data-av_iconfont=\"entypo-fontello\" title=\"\" data-avia-related-tooltip=\"Share on WhatsApp\" rel=\"noopener\"><span class='avia_hidden_link_text'>Share on WhatsApp<\/span><\/a><\/li><li class='av-share-link av-social-link-linkedin' ><a target=\"_blank\" aria-label=\"Share on LinkedIn\" href=\"https:\/\/linkedin.com\/shareArticle?mini=true&#038;title=Siemens%20Healthineers%20and%20Sysmex%20establish%20global%20agreement%20to%20supply%20hemostasis%20instruments%2C%20reagents%20as%20OEMs&#038;url=https:\/\/clinlabint.com\/siemens-healthineers-and-sysmex-establish-global-agreement-to-supply-hemostasis-instruments-reagents-as-oems\/\" aria-hidden=\"false\" data-av_icon=\"\ue8fc\" data-av_iconfont=\"entypo-fontello\" title=\"\" data-avia-related-tooltip=\"Share on LinkedIn\" rel=\"noopener\"><span class='avia_hidden_link_text'>Share on LinkedIn<\/span><\/a><\/li><li class='av-share-link av-social-link-mail' ><a  aria-label=\"Share by Mail\" href='mailto:?subject=Siemens%20Healthineers%20and%20Sysmex%20establish%20global%20agreement%20to%20supply%20hemostasis%20instruments%2C%20reagents%20as%20OEMs&#038;body=https:\/\/clinlabint.com\/siemens-healthineers-and-sysmex-establish-global-agreement-to-supply-hemostasis-instruments-reagents-as-oems\/' aria-hidden='false' data-av_icon='\ue805' data-av_iconfont='entypo-fontello' title='' data-avia-related-tooltip='Share by Mail'><span class='avia_hidden_link_text'>Share by Mail<\/span><\/a><\/li><\/ul><\/div><\/div><\/p><\/div><div class=\"flex_column av_one_fifth  av-hide-on-mobile  flex_column_div av-zero-column-padding   avia-builder-el-10  el_after_av_three_fifth  avia-builder-el-last  \" style='border-radius:0px; '><section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p style=\"text-align: center\"><\/p>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Building on a 25+ year partnership, the companies will each provide one of the largest hemostasis testing system and reagent portfolios to laboratories. Under the multi-year agreement, both companies will individually distribute their combined portfolio of hemostasis instruments and reagents worldwide under their respective own brands.<\/p>\n","protected":false},"author":3,"featured_media":18966,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[35],"tags":[],"class_list":["post-18965","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-e-news"],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/18965"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=18965"}],"version-history":[{"count":2,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/18965\/revisions"}],"predecessor-version":[{"id":18968,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/18965\/revisions\/18968"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media\/18966"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=18965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=18965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=18965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}